Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study

British Medical Journal

Volumn 314, Issue 7083, 1997, Pages 783-788

  Gall, Mari Anne ^a   Hougaard, Philip ^c   Borch Johnsen, Knut ^b   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RETINOPATHY; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; ALBUMINURIA; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030934033     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy, In: Brenner BM, ed. Brenner and Rector's the kidney. 5th ed. Philadelphia: Saunders. 1995:1864-92.
2. Mogensen CE, Chachati A, Christensen CK, Deckert T, Hommel E, Kastrup J, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1986;9:85-95.
3. Parving H-H, Oxenbøll B, Svendsen PAa, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion rate. Acta Endocrinol 1982;100:550-5.
4. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430-2.
5. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:189-93.
6. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PAa, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984;26:406-10.
7. Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993;306:1235-9.
8. Powrie JK, Watts GF, Ingham JN, Taub NN, Talmud PJ, Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ 1994;309:1608-12.
9. Mathisen ER, Rønn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995;12:482-7.
10. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 1995;44:916-23.
11. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81.
12. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993;341:1306-9.
13. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
14. Microalbuminuria Collaborative Study Group, United Kingdom. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ 1995;311:973-7.
15. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P, Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092-5.
16. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. BMJ 1991;303:81-7.
17. Viberti GC, Mogensen CE, Groop L, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-9.
18. Schmitz A, Væth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994;37:1251-8.
19. Hother-Nielsen O, Faber O, Sørensen NS, Beck-Nielsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1988;11:531-7.
20. Faber OK, Binder C. C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus. Diabetes 1997;26:605-10.
21. Blackburn H, Keys A, Simonsen E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation 1960;21:1160-75.
22. Christensen C, Ørskov C. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diabet Nephropathy 1984;3:92-4.
23. 1, by thin layer isoelectric focusing. J Chromatogy 1980;182:325-33.
24. Ullmann R, Bonitz K. Vollmechanisierte kinetische Messung von Kreatinin. Medizinische Laboratorium 1976;29:137-45.
25. Kattermann R, Jaworek D, Möller G. Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 1984;22:245-51.
26. Andersen PK, Borgan Ø, Gill R, Keiding N. Statistical models based on counting processes. New York: Springer, 1993.
27. Cox DR. Regression models and life tables. J Roy Statist Soc B 1972;34:187-220.
28. John L, Sunder Rao PSS, Kanagasabapathy AS. Rate of progression of albuminuria in type II diabetes. Diabetes Care 1994;17:888-90.
29. Nelson RG, Knowler WC, Pettitt DJ, Hanson RL, Bennett PH. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 1995;18:182-7.
30. Gall M-A, Rossing P, Skøtt P, Damsho P, Vagg A, Bech K, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34:655-61.
31. Gall M-A, Borch-Jolmsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303-9.
32. Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 1995;47:1703-20.
33. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes meelitus a randomised prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
34. Moorhead JF, El-Nahas M, Chan MK, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982;ii:1309-11.
35. Ravid M, Neumann L, Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type 2: effect of ACE inhibitors. Kidney Int 1995;47:907-10.
36. Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the ouset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993;36:998-1001.
37. Gall M-A, Nielsen FS, Smidt UM, Parving H-H. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993;36:1071-8.
38. Parving H-H, Gall M-A, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41:758-62.